You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海辰藥業(300584.SZ):消化類產品收入佔比較小 對公司經營業績影響很小
格隆匯 01-27 16:59

格隆匯1月27日丨海辰藥業(300584.SZ)發佈股票交易異常波動公吿,公司注意到近期關於幽門螺旋桿菌相關市場熱點的討論。公司消化類產品包括蘭索拉唑腸溶片、注射用奧美拉唑鈉、注射用艾司奧美拉唑鈉、注射用蘭索拉唑,其適應症包括胃潰瘍、十二指腸潰瘍、反流性食管炎、卓-艾綜合徵(Zollinger-Ellison綜合徵)等。截至2021年三季度,上述產品收入佔比小於6%(該數據未經審計),對公司經營業績影響很小。公司提醒投資者審慎決策、理性投資,注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account